BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1712062)

  • 41. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
    Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
    Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients.
    Hogan BV; Peter MB; Shenoy H; Horgan K; Shaaban A
    Surg Oncol; 2010 Mar; 19(1):11-6. PubMed ID: 19171479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
    Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer.
    Guan X; Dong Y; Fan Z; Zhan Y; Xie X; Xu G; Zhang Y; Guo G; Shi A
    J Int Med Res; 2021 Oct; 49(10):3000605211047279. PubMed ID: 34644211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
    Shen J; Hunt KK; Mirza NQ; Krishnamurthy S; Singletary SE; Kuerer HM; Meric-Bernstam F; Feig B; Ross MI; Ames FC; Babiera GV
    Cancer; 2004 Sep; 101(6):1330-7. PubMed ID: 15316905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement.
    Shigematsu H; Taguchi K; Koui H; Ohno S
    Ann Surg Oncol; 2015 Jul; 22(7):2365-71. PubMed ID: 25476029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
    Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
    Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
    Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
    J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
    Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
    Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
    Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. THE SIGNIFICANCE OF REGIONAL LUMPH NODE METASTASES IN BREAST CARCINOMA.
    DEVITT JE
    Can Med Assoc J; 1965 Aug; 93(7):289-93. PubMed ID: 14319790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
    Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
    Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
    Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.